4,5-Dimethoxycanthin-6-one Inhibits Glioblastoma Stem Cell and Tumor Growth by Inhibiting TSPAN1 Interaction with TM4SF1

Lapointe S, Perry A, Butowski NA (2018) Primary brain tumours in adults. Lancet 392:432–446. https://doi.org/10.1016/s0140-6736(18)30990-5

Article  PubMed  Google Scholar 

Schaff LR, Mellinghoff IK (2023) Glioblastoma and other primary brain malignancies in adults: a review. JAMA 329:574–587. https://doi.org/10.1001/jama.2023.0023

Article  PubMed  Google Scholar 

Hotchkiss KM, Sampson JH (2021) Temozolomide treatment outcomes and immunotherapy efficacy in brain tumor. J Neurooncol 151:55–62. https://doi.org/10.1007/s11060-020-03598-2

Article  CAS  PubMed  Google Scholar 

Morelli M, Lessi F, Barachini S, Liotti R, Montemurro N, Perrini P et al (2022) Metabolic-imaging of human glioblastoma live tumors: a new precision-medicine approach to predict tumor treatment response early. Front Oncol 12:969812. https://doi.org/10.3389/fonc.2022.969812

Article  CAS  PubMed  PubMed Central  Google Scholar 

Vigneswaran K, Boyd NH, Oh SY, Lallani S, Boucher A, Neill SG et al (2021) YAP/TAZ transcriptional coactivators create therapeutic vulnerability to Verteporfin in EGFR-mutant Glioblastoma. Clin Cancer Res 27:1553–1569. https://doi.org/10.1158/1078-0432.Ccr-20-0018

Article  CAS  PubMed  Google Scholar 

Rasheed S, Rehman K, Akash MSH (2021) An insight into the risk factors of brain tumors and their therapeutic interventions. Biomed Pharmacother 143:112119. https://doi.org/10.1016/j.biopha.2021.112119

Article  CAS  PubMed  Google Scholar 

Bausart M, Préat V, Malfanti A (2022) Immunotherapy for glioblastoma: the promise of combination strategies. J Exp Clin Cancer Res 41:35. https://doi.org/10.1186/s13046-022-02251-2

Article  CAS  PubMed  PubMed Central  Google Scholar 

Chen P, Hsu WH, Chang A, Tan Z, Lan Z, Zhou A et al (2020) Circadian Regulator CLOCK recruits Immune-Suppressive Microglia into the GBM Tumor Microenvironment. Cancer Discov 10:371–381. https://doi.org/10.1158/2159-8290.Cd-19-0400

Article  CAS  PubMed  PubMed Central  Google Scholar 

Natarajan SK, Venneti S (2022) Glioblastoma stem cell HISTArionics. Cell Stem Cell 29:1509–1510. https://doi.org/10.1016/j.stem.2022.10.004

Article  CAS  PubMed  Google Scholar 

Liu J, Wang X, Chen AT, Gao X, Himes BT, Zhang H et al (2022) ZNF117 regulates glioblastoma stem cell differentiation towards oligodendroglial lineage. Nat Commun 13:2196. https://doi.org/10.1038/s41467-022-29884-3

Article  CAS  PubMed  PubMed Central  Google Scholar 

Yun EJ, Kim D, Kim S, Hsieh JT, Baek ST (2023) Targeting Wnt/β-catenin-mediated upregulation of oncogenic NLGN3 suppresses cancer stem cells in glioblastoma. Cell Death Dis 14:423. https://doi.org/10.1038/s41419-023-05967-x

Article  CAS  PubMed  PubMed Central  Google Scholar 

Xu M, Sun J, Yu Y, Pang Q, Lin X, Barakat M et al (2020) TM4SF1 involves in miR-1-3p/miR-214-5p-mediated inhibition of the migration and proliferation in keloid by regulating AKT/ERK signaling. Life Sci 254:117746. https://doi.org/10.1016/j.lfs.2020.117746

Article  CAS  PubMed  Google Scholar 

Tang Q, Chen J, Di Z, Yuan W, Zhou Z, Liu Z et al (2020) TM4SF1 promotes EMT and cancer stemness via the Wnt/β-catenin/SOX2 pathway in colorectal cancer. J Exp Clin Cancer Res 39:232. https://doi.org/10.1186/s13046-020-01690-z

Article  CAS  PubMed  PubMed Central  Google Scholar 

Yang SB, Zhou ZH, Lei J, Li XW, Chen Q, Li B et al (2023) TM4SF1 upregulates MYH9 to activate the NOTCH pathway to promote cancer stemness and lenvatinib resistance in HCC. Biol Direct 18:18. https://doi.org/10.1186/s13062-023-00376-8

Article  CAS  PubMed  PubMed Central  Google Scholar 

Gao H, Chakraborty G, Zhang Z, Akalay I, Gadiya M, Gao Y et al (2016) Multi-organ site metastatic reactivation mediated by non-canonical discoidin domain receptor 1 signaling. Cell 166:47–62. https://doi.org/10.1016/j.cell.2016.06.009

Article  CAS  PubMed  PubMed Central  Google Scholar 

Ma YS, Yu F, Zhong XM, Lu GX, Cong XL, Xue SB et al (2018) miR-30 family reduction maintains Self-Renewal and promotes tumorigenesis in NSCLC-Initiating cells by Targeting Oncogene TM4SF1. Mol Ther 26:2751–2765. https://doi.org/10.1016/j.ymthe.2018.09.006

Article  CAS  PubMed  PubMed Central  Google Scholar 

Chen G, She X, Yin Y, Ma J, Gao Y, Gao H et al (2022) Targeting TM4SF1 exhibits therapeutic potential via inhibition of cancer stem cells. Signal Transduct Target Ther 7:350. https://doi.org/10.1038/s41392-022-01177-7

Article  CAS  PubMed  PubMed Central  Google Scholar 

Garcia-Mayea Y, Mir C, Carballo L, Sánchez-García A, Bataller M, ME LL (2022) TSPAN1, a novel tetraspanin member highly involved in carcinogenesis and chemoresistance. Biochim Biophys Acta Rev Cancer 1877:188674. https://doi.org/10.1016/j.bbcan.2021.188674

Article  CAS  PubMed  Google Scholar 

Wang S, Liu X, Khan AA, Li H, Tahir M, Yan X et al (2020) miR-216a-mediated upregulation of TSPAN1 contributes to pancreatic cancer progression via transcriptional regulation of ITGA2. Am J Cancer Res 10:1115–1129

PubMed  PubMed Central  Google Scholar 

Tian J, Zhang R, Piao H, Li X, Sheng W, Zhou J et al (2018) Silencing Tspan1 inhibits migration and invasion, and induces the apoptosis of human pancreatic cancer cells. Mol Med Rep 18:3280–3288. https://doi.org/10.3892/mmr.2018.9331

Article  CAS  PubMed  PubMed Central  Google Scholar 

Garcia-Mayea Y, Mir C, Carballo L, Castellvi J, Temprana-Salvador J, Lorente J et al (2020) TSPAN1: A Novel protein involved in Head and Neck Squamous Cell Carcinoma Chemoresistance. Cancers (Basel). 12. https://doi.org/10.3390/cancers12113269

Huang R, Sun H, Lin R, Zhang J, Yin H, Xian S et al (2022) The role of tetraspanins pan-cancer. iScience 25:104777. https://doi.org/10.1016/j.isci.2022.104777

Article  CAS  PubMed  PubMed Central  Google Scholar 

Miao X, You J, Wang J, Chen Y (2017) In vitro metabolism of 4, 5-dimethoxycanthin-6-one by human liver microsomes and its inhibition on human CYP1A2. Life Sci 190:46–51. https://doi.org/10.1016/j.lfs.2017.09.031

Article  CAS  PubMed  Google Scholar 

Li W, Huang BS, Xiong YY, Yang LJ, Wu LX (2022) 4,5-Dimethoxycanthin-6-one is a novel LSD1 inhibitor that inhibits proliferation of glioblastoma cells and induces apoptosis and pyroptosis. Cancer Cell Int 22:32. https://doi.org/10.1186/s12935-021-02434-5

Article  CAS  PubMed  PubMed Central  Google Scholar 

Zang J, Zheng MH, Cao XL, Zhang YZ, Zhang YF, Gao XY et al (2020) Adenovirus infection promotes the formation of glioma stem cells from glioblastoma cells through the TLR9/NEAT1/STAT3 pathway. Cell Commun Signal 18:135. https://doi.org/10.1186/s12964-020-00598-7

Article  CAS  PubMed  PubMed Central  Google Scholar 

Wang X, Zhou W, Li X, Ren J, Ji G, Du J et al (2020) Graphene oxide suppresses the growth and malignancy of glioblastoma stem cell-like spheroids via epigenetic mechanisms. J Transl Med 18:200. https://doi.org/10.1186/s12967-020-02359-z

Article  CAS  PubMed  PubMed Central  Google Scholar 

Pan W, Li W, Wu H, Xie X, Xie M, Nie Q et al (2023) Aging-accelerated mouse prone 8 (SAMP8) mice experiment and network pharmacological analysis of aged Liupao Tea Aqueous Extract in delaying the decline changes of the body. Antioxidants (Basel). 12.

Comments (0)

No login
gif